Future Outlook: The Next Generation of Biosimilars and the Expansion into Rare Diseases
As the first generation of biosimilars becomes well-established, the industry is looking toward more complex molecules. The next wave will likely include biosimilars for orphan drugs, which are used to treat rare diseases. While the patient population for these drugs is smaller, the high cost per patient makes biosimilar development commercially viable. This expansion represents a new frontier...
0 Σχόλια 0 Μοιράστηκε 38 Views 0 Προεπισκόπηση
JogaJog https://jogajog.com.bd